Alkem Laboratories · NSE: ALKEM · BSE: 539523
Q2 FY19 results · Jul–Sep 2018
Alkem Laboratories reported revenue from operations of ₹1,918.92 crore and net profit of ₹260.42 crore for Q2 FY19 (Jul–Sep 2018), on a consolidated basis.
| Item | Q2 FY19 | Q2 FY18 | YoY | Q1 FY19 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 1,918.92 | — | — | 1,669.46 | +14.9% |
| Other income | 24.02 | — | — | 16.25 | +47.8% |
| Total income | 1,942.94 | — | — | 1,685.71 | +15.3% |
| Profit before tax | 326.02 | — | — | 171.77 | +89.8% |
| Net profit for the period | 260.42 | — | — | 137.27 | +89.7% |
| Attributable to shareholders of the company | 254.47 | — | — | 136.15 | +86.9% |
| EPS, basic (₹) | 21.28 | — | — | 11.39 | +86.9% |
| Net margin (%) | 13.6 | — | 8.2 |
| Item | Q2 FY19 | Q2 FY18 | YoY | Q1 FY19 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 1,440.22 | — | — | 1,280.36 | +12.5% |
| Other income | 23.43 | — | — | 8.97 | +161.2% |
| Total income | 1,463.65 | — | — | 1,289.33 | +13.5% |
| Profit before tax | 284.77 | — | — | 157.62 | +80.7% |
| Net profit for the period | 238.30 | — | — | 129.49 | +84.0% |
| EPS, basic (₹) | 19.93 | — | — | 10.83 | +84.0% |
| Net margin (%) | 16.5 | — | 10.1 |
Consolidated
- Filed with BSE
- 02 Nov 2018, 18:10 IST
- Board meeting
- 02 Nov 2018
- Period
- 01 Jul 2018 to 30 Sep 2018
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 02 Nov 2018, 18:10 IST
- Board meeting
- 02 Nov 2018
- Period
- 01 Jul 2018 to 30 Sep 2018
- Review status
- Unaudited
- Source
- XBRL filing on BSE